DJIA 16,399.67 19.26 0.12%
NASDAQ 4,316.07 57.64 1.35%
S&P 500 1,904.01 17.25 0.91%
market minute promo

124.78 4.57 (3.80%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $124.78 3.80%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $121.13
Previous Close $120.21
Daily Range $120.12 - $127.43
52-Week Range $102.60 - $153.10
Market Cap $41.6B
P/E Ratio -51.15
Dividend (Yield) $0.00 (0.0%)
Volume 3,400,991
Average Daily Volume 2,953,464
Current FY EPS $2.96

Sector

Healthcare

Industry

Drugs

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

Actavis plc and Valeant Pharmaceuticals Inc. Battle for Allergan Inc.: Who Wins?

Valeant Pharmaceuticals upped its bid offer for Botox maker Allergan by $15 a share yesterday. Actavis reportedly responded with an even richer offer. Will activist investor Bill Ackman get his way or will six months of work go down the drain?

Report: Actavis, Sanofi To Bid On Over-The-Counter Drug Maker

Can Valeant's Strong Q3 Entice Allergan?

VALEANT PHARMACEUTICALS INTL (VRX) Earnings Report: Q3 2014 Conference Call Transcript

Valeant Pharmaceuticals International's (VRX) CEO Mike Pearson on Q3 2014 Results - Earnings Call Tr

Valeant Pharmaceuticals International's (VRX) CEO Mike Pearson on Q3 2014 Results - Earnings Call Transcript

Jim Cramer: Valeant Pharmaceuticals and Allergan Are Winners

Today's Market: Tech And Pharma Earnings Moving The Market

In the news: Earnings season marches on, Yahoo plans

UPDATE: Valeant Pharmaceuticals Posts Upbeat Q3 Earnings, Lifts Forecast

Stocks: 4 things to know before the open

Premarkets: 4 things to know before the open

Pre-Market Earnings Report for October 20, 2014 : HAL, VRX, VFC, GPC, HAS, GCI, LII, BTU, SAP, CBU,

Pre-Market Earnings Report for October 20, 2014 : HAL, VRX, VFC, GPC, HAS, GCI, LII, BTU, SAP, CBU, BMRC, PETS

See More VRX News...

VRX's Top Competitors

VRX $124.78 (3.80%)
Current stock: VRX
JNJ $99.20 (0.51%)
Current stock: JNJ
NVS $87.90 (1.47%)
Current stock: NVS
RHHBY $35.85 (1.26%)
Current stock: RHHBY